Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_assertion type Assertion NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_head.
- NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_assertion description "[The risk of GvHD furthermore increased when recipients heterozygous for HLA-C KIR ligand groups (C1/C2) were transplanted from donors completely lacking activating KIRs (HR 6.1, 95% CI 1.9-19.2, P = 0.002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_provenance.
- NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_assertion evidence source_evidence_literature NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_provenance.
- NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_assertion SIO_000772 22077388 NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_provenance.
- NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_assertion wasDerivedFrom befree-2016 NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_provenance.
- NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_assertion wasGeneratedBy ECO_0000203 NP938203.RAFIa2P0sbJ4iaT8oG4czqoR3vx1n2ScmUlmQc_hSKZuM130_provenance.